首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1468305

2024-2032 年按產品類型、技術、應用和地區分類的數位 PCR 市場報告

Digital PCR Market Report by Product Type, Technology, Application, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球IMARC GroupPCR市場規模達47億美元。核酸鑑定精度的提高、液體活體組織切片需求的增加、基因組研究的重大進步、生物技術和製藥行業的擴大以及廣泛的研究和投資活動是推動市場的一些主要因素。

數位 PCR（或數位聚合酶鍊式反應）是一種高度精確且先進的分子生物學技術，用於在各種應用中定量和分析核酸（例如 DNA 和 RNA）。與僅提供單一終點測量的傳統 PCR 不同，數位 PCR 將樣本分為數千個微小的單獨反應，無論是物理反應還是數位反應。這樣可以對目標核酸進行絕對定量，從而提供無與倫比的靈敏度和準確性。數位 PCR 在基因組學、臨床診斷和環境監測等領域發揮重要作用。它檢測罕見突變、量化基因表現和評估病毒量的能力使其成為了解遺傳疾病、監測治療反應和研究微生物群落的寶貴工具。其定量特性和對抑制劑的敏感度極低，使其在關鍵應用上高度可靠。

數位 PCR 在核酸定量方面具有卓越的準確性和靈敏度，使其成為基因組學、診斷和藥物研究中不可或缺的工具。此外，用於癌症檢測和監測的液體活體組織切片也越來越受到關注。 dPCR 檢測血液和其他體液中罕見突變和拷貝數變異的能力推動了其在這一關鍵領域的採用。除此之外，dPCR 在診斷傳染病、遺傳性疾病和監測病毒量方面發揮關鍵作用。在新冠肺炎 (COVID-19) 大流行等全球健康問題的背景下，這一點尤其重要。除此之外，生技和製藥產業不斷需要強大的研發工具。 dPCR 透過在藥物開發和生物製造過程中實現精確定量來滿足這一需求。與此一致的是，環境監測（包括水和土壤中病原體的檢測）依賴 dPCR 在檢測低濃度污染物方面的準確性和可靠性。此外，在了解遺傳對疾病的影響和開發個人化醫療的需求的推動下，基因組研究正在不斷擴大。 dPCR 有助於精確的遺傳分析，有助於突破性的發現。

數位 PCR 市場趨勢/促進因素：

提高核酸定量的精確度

數位 PCR 在核酸定量方面提供了無與倫比的精確度。與依賴相對測量的傳統定量 PCR (qPCR) 不同，dPCR 提供絕對定量。這種精度是透過將樣品分配到數千個單獨的反應中來實現的，從而有效地計算存在的目標分子的數量。這種準確性水平在各種應用中至關重要，例如檢測癌症中的罕見基因突變、確保診斷測試的可靠性以及追蹤傳染病中的病毒載量變化。

液體切片的需求不斷成長

液體活體組織切片涉及分析血液或其他體液中與癌症相關的生物標記物，在早期癌症檢測和治療監測中變得越來越重要。數位 PCR 的靈敏度能夠檢測微量的突變 DNA 或 RNA，使其成為液體活體組織切片檢測的關鍵技術。臨床醫生可以使用 dPCR 來識別與各種癌症相關的特定基因突變，為個人化治療策略提供有價值的資訊。

基因組研究的重大進展

在了解疾病遺傳基礎和開發標靶治療的需求的推動下，基因組學領域不斷發展。數位 PCR 在這項研究中發揮核心作用，它使科學家能夠精確量化基因表現、檢測罕見的遺傳變異並研究拷貝數變異。這些能力對於發現導致疾病的遺傳因素、識別潛在的藥物標靶和最佳化治療干預措施至關重要。隨著基因組研究的擴展，對 dPCR 作為在遺傳分析中提供準確性和可重複性的工具的需求也在增加。

The global digital PCR market size reached US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.7 Billion by 2032, exhibiting a growth rate (CAGR) of 9.25% during 2024-2032. The increased precision in nucleic acid qualification, rising demand for liquid biopsies, significant advancements in genomic research, expanding biotechnology and pharmaceutical industries, and extensive research and investment activities are some of the major factors propelling the market.

Digital PCR, or digital polymerase chain reaction, is a highly precise and advanced molecular biology technique used for quantifying and analyzing nucleic acids, such as DNA and RNA, in various applications. Unlike traditional PCR, which provides only a single endpoint measurement, digital PCR partitions the sample into thousands of tiny individual reactions, either physically or digitally. This allows for the absolute quantification of the target nucleic acid, offering unparalleled sensitivity and accuracy. Digital PCR is instrumental in fields like genomics, clinical diagnostics, and environmental monitoring. Its ability to detect rare mutations, quantify gene expression, and assess viral loads has made it a valuable tool in understanding genetic diseases, monitoring treatment responses, and studying microbial communities. Its quantitative nature and minimal susceptibility to inhibitors make it highly reliable in critical applications.

Digital PCR offers superior accuracy and sensitivity in nucleic acid quantification, making it an indispensable tool in genomics, diagnostics, and pharmaceutical research. Additionally, liquid biopsies for cancer detection and monitoring are gaining traction. The ability of dPCR to detect rare mutations and copy number variations in blood and other bodily fluids fuels its adoption in this critical field. Other than this, dPCR plays a pivotal role in diagnosing infectious diseases, genetic disorders, and monitoring viral loads. This is particularly crucial in the context of global health concerns, such as the COVID-19 pandemic. Besides this, the biotech and pharmaceutical sectors continually demand robust tools for research and development. dPCR meets this need by enabling precise quantification in drug development and biomanufacturing processes. In line with this, environmental monitoring, including the detection of pathogens in water and soil, relies on dPCR for its accuracy and reliability in detecting low-level contaminants. Moreover, genomic research is expanding, driven by the need to understand genetic contributions to diseases and develop personalized medicine. dPCR facilitates precise genetic analysis, aiding in breakthrough discoveries.

Digital PCR Market Trends/Drivers:

Increased Precision in Nucleic Acid Quantification

Digital PCR offers an unparalleled level of precision in quantifying nucleic acids. Unlike traditional quantitative PCR (qPCR), which relies on relative measurements, dPCR provides absolute quantification. This precision is achieved by partitioning the sample into thousands of separate reactions, effectively counting the number of target molecules present. This level of accuracy is essential in various applications, such as detecting rare genetic mutations in cancer, ensuring the reliability of diagnostic tests, and tracking viral load changes in infectious diseases.

Rising Demand for Liquid Biopsies

Liquid biopsies, which involve analyzing blood or other bodily fluids for cancer-related biomarkers, are becoming increasingly important in early cancer detection and treatment monitoring. Digital PCR's sensitivity enables the detection of minute amounts of mutated DNA or RNA, making it a pivotal technology in liquid biopsy assays. Clinicians can use dPCR to identify specific genetic mutations associated with various cancers, providing valuable information for personalized treatment strategies.

Significant Advancements in Genomic Research

The field of genomics continues to evolve, driven by the need to understand the genetic basis of diseases and develop targeted therapies. Digital PCR plays a central role in this research by allowing scientists to precisely quantify gene expression, detect rare genetic variants, and study copy number variations. These capabilities are vital for uncovering genetic factors contributing to diseases, identifying potential drug targets, and optimizing therapeutic interventions. As genomic research expands, so does the demand for dPCR as a tool that offers both accuracy and reproducibility in genetic analysis.

Digital PCR Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global digital PCR market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, technology and application.

Breakup by Product Type:

Digital PCR Equipment

Consumables and Reagents

Software and Services

Digital PCR equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes digital PCR equipment, consumables and reagents, and software and service. According to the report, digital PCR equipment represented the largest segment.

The pivotal role of digital PCR equipment in molecular biology and genetic research positions it as a fundamental tool in laboratories worldwide. The demand for precise nucleic acid quantification, which digital PCR equipment excels in, continues to rise across various applications, including genomics, diagnostics, and environmental monitoring. Additionally, as scientific understanding advances and the need for high-throughput and sensitive techniques grows, digital PCR equipment stands out as the preferred choice. Its ability to detect and quantify rare genetic mutations, copy number variations, and low-level viral loads has made it indispensable in fields like cancer research, infectious disease diagnostics, and monitoring of genetic disorders. Furthermore, ongoing technological advancements in digital PCR platforms, automation, and integration with other laboratory systems have made this equipment more user-friendly and efficient, driving its adoption in both research and clinical settings.

Breakup by Technology:

Droplet Digital PCR

BEAMing Digital PCR

Droplet digital PCR holds the largest share in the market

A detailed breakup and analysis of the market based on technology has also been provided in the report. This includes droplet digital PCR and BEAMing digital PCR. According to the report, droplet digital PCR accounted for the largest market share.

Droplet digital PCR (ddPCR), combines the precision of digital PCR (dPCR) with increased throughput, making it an attractive choice for researchers and diagnosticians. This technology partitions a sample into thousands of tiny droplets, each serving as an individual reaction vessel. This parallelization significantly enhances the sensitivity and accuracy of nucleic acid quantification. Additionally, ddPCR excels in applications that require absolute quantification, especially in situations where rare mutations, copy number variations, or low-abundance targets need to be detected. Its ability to provide an absolute count of target molecules within a sample, rather than relying on relative measurements, is a significant advantage in genomics, cancer research, and clinical diagnostics. Other than this, ddPCR offers robustness in the presence of inhibitors, making it suitable for challenging sample types, such as those found in environmental monitoring or clinical specimens. This resilience to inhibitory substances enhances the reliability and versatility of technology.

Breakup by Application:

Clinical Diagnostics

Forensics

Research

Others

Clinical diagnostics dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes clinical diagnostics, forensics, research, and others. According to the report, clinical diagnostics represented the largest segment.

The ever-growing emphasis on healthcare and wellness globally has spurred an increased demand for accurate and timely diagnostic tests. As the population ages and health concerns become more prevalent, the need for early disease detection and monitoring has surged, leading to a substantial uptick in clinical diagnostic services. Furthermore, advancements in technology have played a pivotal role in enhancing the precision and speed of diagnostic procedures, making them more accessible and reliable. In addition, the COVID-19 pandemic brought to the forefront the importance of diagnostic testing, underscoring the critical role of clinical diagnostics in public health.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America has a well-established and highly sophisticated healthcare infrastructure, including a robust network of clinical laboratories and research institutions. This infrastructure fosters the adoption of advanced molecular diagnostic techniques like dPCR, particularly in the United States and Canada, where healthcare expenditure is substantial. Additionally, the region is at the forefront of genomics and personalized medicine research. The demand for precise nucleic acid quantification technologies like dPCR is driven by the region's extensive genomic research initiatives and the increasing emphasis on tailoring medical treatments to individual patients. Other than this, the region has a thriving biotechnology and pharmaceutical industry that relies heavily on dPCR for drug development, clinical trials, and quality control processes. The versatility and accuracy of dPCR technology make it an essential tool in these sectors. Furthermore, North America has been quick to adopt innovative diagnostic technologies, especially in response to public health crises like the COVID-19 pandemic. The use of dPCR for virus detection and monitoring has further propelled its growth in the region.

Competitive Landscape:

Leading companies consistently invest in R&D to develop innovative dPCR platforms with improved sensitivity, automation, and scalability. These advancements cater to the evolving needs of researchers and clinicians across various applications. Additionally, numerous major players have established collaborations with academic institutions, research organizations, and other industry stakeholders. These partnerships facilitate the exchange of knowledge, expertise, and resources, leading to the development of cutting-edge dPCR technologies. Other than this, to address a wide range of applications, key players have expanded their product portfolios to include different dPCR platforms and consumables. This allows them to cater to diverse customer needs and preferences. Besides this, companies have pursued strategies to expand their presence in emerging markets, capitalizing on the increasing adoption of dPCR technologies in regions with growing healthcare and biotechnology sectors. In line with this, key players invest in marketing campaigns to raise awareness about the benefits of dPCR. These efforts target both existing and potential customers, highlighting the advantages of technology in research, diagnostics, and other applications.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Avance Biosciences Inc.

Bio-Rad Laboratories Inc.

Danaher Corporation

JN Medsys

OPTOLANE Technologies Inc.

QIAGEN

SAGA Diagnostics AB

Standard BioTools Inc.

Stilla Technologies

Sysmex Corporation

Thermo Fisher Scientific Inc.

Recent Developments:

Standard Bio Tools Inc. has recently unveiled the X9 Real-Time PCR System, a cutting-edge genomics instrument designed to deliver exceptional efficiency. This innovative device boasts a high capacity, making it a standout choice for genomics research. The X9 Real-Time PCR System represents a significant advancement in the field, enabling researchers to perform real-time polymerase chain reactions with remarkable precision. Its high capacity ensures that a wide range of genetic analyses can be conducted efficiently and effectively.

Stilla Technologies and Promega Corporation have joined forces through a strategic co-marketing agreement, bringing together the expertise of both companies in the realms of sample preparation and cutting-edge genomics technology. This collaboration focuses on harnessing the power of the latest Maxwell systems and digital polymerase chain reaction (PCR) using the six-color Naica system. The partnership between Stilla and Promega Corporation signifies a significant step forward in the field of molecular biology and genomics. By integrating the capabilities of Maxwell systems and digital PCR on the Naica platform, researchers will gain access to a comprehensive and highly advanced solution for their analytical needs.

QIAGEN and GT Molecular have jointly revealed an exciting collaboration aimed at delivering a comprehensive solution for the detection of SARS-CoV-2 in wastewater. This innovative solution is built upon QIAcuity digital PCR technology, signifying a significant advancement in the field of environmental monitoring for viral pathogens. The partnership between QIAGEN and GT Molecular reflects their shared commitment to addressing critical public health challenges, particularly in the context of the ongoing COVID-19 pandemic.

Key Questions Answered in This Report

1. How big is the global digital PCR market?
2. What is the expected growth rate of the global digital PCR market during 2024-2032?
3. What are the key factors driving the global digital PCR market?
4. What has been the impact of COVID-19 on the global digital PCR market?
5. What is the breakup of the global digital PCR market based on the product type?
6. What is the breakup of the global digital PCR market based on the technology?
7. What is the breakup of the global digital PCR market based on the application?
8. What are the key regions in the global digital PCR market?
9. Who are the key players/companies in the global digital PCR market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Digital PCR Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Digital PCR Equipment
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Consumables and Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Droplet Digital PCR
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 BEAMing Digital PCR
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Application

8.1 Clinical Diagnostics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Forensics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Research
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Avance Biosciences Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Bio-Rad Laboratories Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Danaher Corporation
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 JN Medsys
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 OPTOLANE Technologies Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 QIAGEN
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 SAGA Diagnostics AB
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Standard BioTools Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
- 14.3.9 Stilla Technologies
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Sysmex Corporation
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Thermo Fisher Scientific Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Digital PCR Market: Major Drivers and Challenges
Figure 2: Global: Digital PCR Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Digital PCR Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Digital PCR Market: Breakup by Product Type (in %), 2023
Figure 5: Global: Digital PCR Market: Breakup by Technology (in %), 2023
Figure 6: Global: Digital PCR Market: Breakup by Application (in %), 2023
Figure 7: Global: Digital PCR Market: Breakup by Region (in %), 2023
Figure 8: Global: Digital PCR (Digital PCR Equipment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Digital PCR (Digital PCR Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Digital PCR (Consumables and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Digital PCR (Consumables and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Digital PCR (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Digital PCR (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Digital PCR (Droplet Digital PCR) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Digital PCR (Droplet Digital PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Digital PCR (BEAMing Digital PCR) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Digital PCR (BEAMing Digital PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Digital PCR (Clinical Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Digital PCR (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Digital PCR (Forensics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Digital PCR (Forensics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Digital PCR (Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Digital PCR (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Digital PCR (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Digital PCR (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: North America: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: North America: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: United States: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: United States: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Canada: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Canada: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Asia-Pacific: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Asia-Pacific: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: China: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: China: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Japan: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Japan: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: India: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: India: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: South Korea: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: South Korea: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Australia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Australia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Indonesia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Indonesia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Europe: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Europe: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Germany: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Germany: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: France: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: France: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: United Kingdom: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: United Kingdom: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Italy: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Italy: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Spain: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Spain: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Russia: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Russia: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Latin America: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Latin America: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Brazil: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Brazil: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Mexico: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Mexico: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Middle East and Africa: Digital PCR Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Middle East and Africa: Digital PCR Market: Breakup by Country (in %), 2023
Figure 74: Middle East and Africa: Digital PCR Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Global: Digital PCR Industry: SWOT Analysis
Figure 76: Global: Digital PCR Industry: Value Chain Analysis
Figure 77: Global: Digital PCR Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Digital PCR Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Digital PCR Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
Table 3: Global: Digital PCR Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Digital PCR Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Digital PCR Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Digital PCR Market: Competitive Structure
Table 7: Global: Digital PCR Market: Key Players

02-2729-4219

+886-2-2729-4219